IBDEI2XG ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46715,2)
;;=^5015645
;;^UTILITY(U,$J,358.3,46716,0)
;;=Z87.440^^179^2329^26
;;^UTILITY(U,$J,358.3,46716,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46716,1,3,0)
;;=3^Personal Hx of UTI
;;^UTILITY(U,$J,358.3,46716,1,4,0)
;;=4^Z87.440
;;^UTILITY(U,$J,358.3,46716,2)
;;=^5063495
;;^UTILITY(U,$J,358.3,46717,0)
;;=N39.0^^179^2329^36
;;^UTILITY(U,$J,358.3,46717,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46717,1,3,0)
;;=3^UTI,Site Unspec
;;^UTILITY(U,$J,358.3,46717,1,4,0)
;;=4^N39.0
;;^UTILITY(U,$J,358.3,46717,2)
;;=^124436
;;^UTILITY(U,$J,358.3,46718,0)
;;=N31.8^^179^2329^22
;;^UTILITY(U,$J,358.3,46718,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46718,1,3,0)
;;=3^Neuromusc Dysfunction Bladder,Other
;;^UTILITY(U,$J,358.3,46718,1,4,0)
;;=4^N31.8
;;^UTILITY(U,$J,358.3,46718,2)
;;=^5015647
;;^UTILITY(U,$J,358.3,46719,0)
;;=N32.81^^179^2329^25
;;^UTILITY(U,$J,358.3,46719,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46719,1,3,0)
;;=3^Overactive bladder
;;^UTILITY(U,$J,358.3,46719,1,4,0)
;;=4^N32.81
;;^UTILITY(U,$J,358.3,46719,2)
;;=^5015652
;;^UTILITY(U,$J,358.3,46720,0)
;;=M62.838^^179^2329^32
;;^UTILITY(U,$J,358.3,46720,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46720,1,3,0)
;;=3^Spasm,Other Muscle
;;^UTILITY(U,$J,358.3,46720,1,4,0)
;;=4^M62.838
;;^UTILITY(U,$J,358.3,46720,2)
;;=^5012682
;;^UTILITY(U,$J,358.3,46721,0)
;;=N10.^^179^2329^27
;;^UTILITY(U,$J,358.3,46721,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46721,1,3,0)
;;=3^Pyelonephritis,Acute
;;^UTILITY(U,$J,358.3,46721,1,4,0)
;;=4^N10.
;;^UTILITY(U,$J,358.3,46721,2)
;;=^5015570
;;^UTILITY(U,$J,358.3,46722,0)
;;=N11.0^^179^2329^24
;;^UTILITY(U,$J,358.3,46722,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46722,1,3,0)
;;=3^Nonobstructive Reflux-Associated Chronic Pyelonephritis
;;^UTILITY(U,$J,358.3,46722,1,4,0)
;;=4^N11.0
;;^UTILITY(U,$J,358.3,46722,2)
;;=^5015571
;;^UTILITY(U,$J,358.3,46723,0)
;;=N11.1^^179^2329^28
;;^UTILITY(U,$J,358.3,46723,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46723,1,3,0)
;;=3^Pyelonephritis,Chronic Obstructive
;;^UTILITY(U,$J,358.3,46723,1,4,0)
;;=4^N11.1
;;^UTILITY(U,$J,358.3,46723,2)
;;=^5015572
;;^UTILITY(U,$J,358.3,46724,0)
;;=N11.8^^179^2329^35
;;^UTILITY(U,$J,358.3,46724,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46724,1,3,0)
;;=3^Tubulo-Interstitial Nephritis,Oth Chronic
;;^UTILITY(U,$J,358.3,46724,1,4,0)
;;=4^N11.8
;;^UTILITY(U,$J,358.3,46724,2)
;;=^5015573
;;^UTILITY(U,$J,358.3,46725,0)
;;=N11.9^^179^2329^34
;;^UTILITY(U,$J,358.3,46725,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46725,1,3,0)
;;=3^Tubulo-Interstitial Nephritis,Chronic,Unspec
;;^UTILITY(U,$J,358.3,46725,1,4,0)
;;=4^N11.9
;;^UTILITY(U,$J,358.3,46725,2)
;;=^5015574
;;^UTILITY(U,$J,358.3,46726,0)
;;=N12.^^179^2329^33
;;^UTILITY(U,$J,358.3,46726,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46726,1,3,0)
;;=3^Tubulo-Interstitial Nephritis
;;^UTILITY(U,$J,358.3,46726,1,4,0)
;;=4^N12.
;;^UTILITY(U,$J,358.3,46726,2)
;;=^5015575
;;^UTILITY(U,$J,358.3,46727,0)
;;=N13.0^^179^2329^9
;;^UTILITY(U,$J,358.3,46727,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46727,1,3,0)
;;=3^Hydronephrosis w/ Ureteropelvic Junction Obstruction
;;^UTILITY(U,$J,358.3,46727,1,4,0)
;;=4^N13.0
;;^UTILITY(U,$J,358.3,46727,2)
;;=^7494103
;;^UTILITY(U,$J,358.3,46728,0)
;;=N13.1^^179^2329^8
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2XG 3778 printed Nov 22, 2024@17:47:52 Page 2
IBDEI2XG ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46715,2)
+2 ;;=^5015645
+3 ;;^UTILITY(U,$J,358.3,46716,0)
+4 ;;=Z87.440^^179^2329^26
+5 ;;^UTILITY(U,$J,358.3,46716,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,46716,1,3,0)
+8 ;;=3^Personal Hx of UTI
+9 ;;^UTILITY(U,$J,358.3,46716,1,4,0)
+10 ;;=4^Z87.440
+11 ;;^UTILITY(U,$J,358.3,46716,2)
+12 ;;=^5063495
+13 ;;^UTILITY(U,$J,358.3,46717,0)
+14 ;;=N39.0^^179^2329^36
+15 ;;^UTILITY(U,$J,358.3,46717,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,46717,1,3,0)
+18 ;;=3^UTI,Site Unspec
+19 ;;^UTILITY(U,$J,358.3,46717,1,4,0)
+20 ;;=4^N39.0
+21 ;;^UTILITY(U,$J,358.3,46717,2)
+22 ;;=^124436
+23 ;;^UTILITY(U,$J,358.3,46718,0)
+24 ;;=N31.8^^179^2329^22
+25 ;;^UTILITY(U,$J,358.3,46718,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,46718,1,3,0)
+28 ;;=3^Neuromusc Dysfunction Bladder,Other
+29 ;;^UTILITY(U,$J,358.3,46718,1,4,0)
+30 ;;=4^N31.8
+31 ;;^UTILITY(U,$J,358.3,46718,2)
+32 ;;=^5015647
+33 ;;^UTILITY(U,$J,358.3,46719,0)
+34 ;;=N32.81^^179^2329^25
+35 ;;^UTILITY(U,$J,358.3,46719,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,46719,1,3,0)
+38 ;;=3^Overactive bladder
+39 ;;^UTILITY(U,$J,358.3,46719,1,4,0)
+40 ;;=4^N32.81
+41 ;;^UTILITY(U,$J,358.3,46719,2)
+42 ;;=^5015652
+43 ;;^UTILITY(U,$J,358.3,46720,0)
+44 ;;=M62.838^^179^2329^32
+45 ;;^UTILITY(U,$J,358.3,46720,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,46720,1,3,0)
+48 ;;=3^Spasm,Other Muscle
+49 ;;^UTILITY(U,$J,358.3,46720,1,4,0)
+50 ;;=4^M62.838
+51 ;;^UTILITY(U,$J,358.3,46720,2)
+52 ;;=^5012682
+53 ;;^UTILITY(U,$J,358.3,46721,0)
+54 ;;=N10.^^179^2329^27
+55 ;;^UTILITY(U,$J,358.3,46721,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,46721,1,3,0)
+58 ;;=3^Pyelonephritis,Acute
+59 ;;^UTILITY(U,$J,358.3,46721,1,4,0)
+60 ;;=4^N10.
+61 ;;^UTILITY(U,$J,358.3,46721,2)
+62 ;;=^5015570
+63 ;;^UTILITY(U,$J,358.3,46722,0)
+64 ;;=N11.0^^179^2329^24
+65 ;;^UTILITY(U,$J,358.3,46722,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,46722,1,3,0)
+68 ;;=3^Nonobstructive Reflux-Associated Chronic Pyelonephritis
+69 ;;^UTILITY(U,$J,358.3,46722,1,4,0)
+70 ;;=4^N11.0
+71 ;;^UTILITY(U,$J,358.3,46722,2)
+72 ;;=^5015571
+73 ;;^UTILITY(U,$J,358.3,46723,0)
+74 ;;=N11.1^^179^2329^28
+75 ;;^UTILITY(U,$J,358.3,46723,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,46723,1,3,0)
+78 ;;=3^Pyelonephritis,Chronic Obstructive
+79 ;;^UTILITY(U,$J,358.3,46723,1,4,0)
+80 ;;=4^N11.1
+81 ;;^UTILITY(U,$J,358.3,46723,2)
+82 ;;=^5015572
+83 ;;^UTILITY(U,$J,358.3,46724,0)
+84 ;;=N11.8^^179^2329^35
+85 ;;^UTILITY(U,$J,358.3,46724,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,46724,1,3,0)
+88 ;;=3^Tubulo-Interstitial Nephritis,Oth Chronic
+89 ;;^UTILITY(U,$J,358.3,46724,1,4,0)
+90 ;;=4^N11.8
+91 ;;^UTILITY(U,$J,358.3,46724,2)
+92 ;;=^5015573
+93 ;;^UTILITY(U,$J,358.3,46725,0)
+94 ;;=N11.9^^179^2329^34
+95 ;;^UTILITY(U,$J,358.3,46725,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,46725,1,3,0)
+98 ;;=3^Tubulo-Interstitial Nephritis,Chronic,Unspec
+99 ;;^UTILITY(U,$J,358.3,46725,1,4,0)
+100 ;;=4^N11.9
+101 ;;^UTILITY(U,$J,358.3,46725,2)
+102 ;;=^5015574
+103 ;;^UTILITY(U,$J,358.3,46726,0)
+104 ;;=N12.^^179^2329^33
+105 ;;^UTILITY(U,$J,358.3,46726,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,46726,1,3,0)
+108 ;;=3^Tubulo-Interstitial Nephritis
+109 ;;^UTILITY(U,$J,358.3,46726,1,4,0)
+110 ;;=4^N12.
+111 ;;^UTILITY(U,$J,358.3,46726,2)
+112 ;;=^5015575
+113 ;;^UTILITY(U,$J,358.3,46727,0)
+114 ;;=N13.0^^179^2329^9
+115 ;;^UTILITY(U,$J,358.3,46727,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,46727,1,3,0)
+118 ;;=3^Hydronephrosis w/ Ureteropelvic Junction Obstruction
+119 ;;^UTILITY(U,$J,358.3,46727,1,4,0)
+120 ;;=4^N13.0
+121 ;;^UTILITY(U,$J,358.3,46727,2)
+122 ;;=^7494103
+123 ;;^UTILITY(U,$J,358.3,46728,0)
+124 ;;=N13.1^^179^2329^8
